Gubra is seeking a dedicated and experienced Department Manager to lead our newly modified Pharmaceutical Development department within our Biotech business unit. The ideal candidate will possess proven leadership abilities and a passion for managing and developing teams, along with a background in Pharmaceutical Sciences.

The Pharmaceutical Development department plays an important role in supporting Gubra's peptide drug discovery projects with

• Analytical method development and analysis of physicochemical stability and solubility for peptide candidates in discovery and development.
• Formulation development for drug discovery preclinical studies.
• Support for formulation development for clinical trials.

In recent years, we have successfully developed highly automated workflows to enhance our drug screening platform (streaMLine), facilitating high-throughput peptide synthesis and data generation.

With an ambition to grow the company to initiate more clinical trials the department will both expand current capabilities in Research but also increase the breath of the work to include significant support to CMC package of the development projects.

The team currently comprises 4 scientists and 1 (2 more in hiring) technicians and significant expansions are planned. The department is a part of the larger In vitro & Pharmaceutical Research area, which includes Chemistry, DMPK, and Molecular Pharmacology who work collaboratively across the entire drug discovery value chain, engaging in both in-house and partnered projects.

As Department Manager your tasks include

• Daily management of a team of scientists and lab technicians to ensure high performance, personal development, well-being and engagement.
• Guide the team to accomplish department goals and objectives.
• Oversee the planning, execution, and analysis of experiments to support Gubra’s internal and partnered drug discovery projects.
• Engaging in collaborative interactions with other department managers and key internal stakeholders to ensure successful advancement of projects.
• Proactive lead in automatization and digitalization of processes within peptide physicochemical screening and striving for continuous optimization.
• Support to Vice President and Executive Management to implement and execute the company strategy.

Your competencies

• Leadership experience from the biotech/pharmaceutical industry.
• PhD or other equivalent experience within life sciences.
• Expertise in chemical and physical peptide characterization, analytical method development, pre-formulation and formulation development.
• Knowledge of data to support outsourced Drug substance and Drug product production.
• Proven involvement in drug discovery projects, demonstrating contributions across different phases.
• Ability to communicate clearly and concisely.
• Knowledge of laboratory automation and data management is beneficial.

As a person you

• Are passionate about developing people in a dynamic organization.
• Have a positive attitude that motivates people around you.
• Thrive on collaboration, innovation and delivering results.
• Engages in and promotes clear and open communication.
• Are proactive and able to initiate, focus and deliver on tasks and projects.

Please apply no later than February 15, 2026 by uploading your motivated cover letter and resume on our website. Please note that applications will be evaluated on a rolling basis. If you have questions about the position, please contact Vice President, In vitro & Pharmaceutical Research, Mette Svendgaard at MSV@gubra.dk.

About Gubra

Gubra is a disease-agnostic techbio company specialized in peptide-based drug discovery and preclinical contract research services striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the path towards a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.

Gubra’s activities are focused on the early stages of drug development and are organised in two main highly synergistic business areas: Biotech and CRO Services. We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.

Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.

People are our greatest asset, and our team consists of around 300 employees of which many are located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!